M&A Deal Summary |
|
|---|---|
| Date | 2024-05-01 |
| Target | HORUS Scientific |
| Sector | Healthcare Services |
| Buyer(s) | Veranex |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2021 |
| Sector | Business Services |
Veranex is a comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance for each of its four concept-through-commercialization pillars: engineering and design, clinical, market access, and regulatory. The company enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, its customers realize efficiencies in cost and time, while its comprehensive solutions unify the entire development process. Veranex was founded in 2021 and is based in Raleigh, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 12 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 12 of 12 |
| State: Massachusetts M&A | 2 of 2 |
| Country: United States M&A | 8 of 8 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-12-13 |
T3 Labs
Atlanta, Georgia, United States T3 Labs is a provider in preclinical evaluation services in the United States and boasts a 33,000-square-foot facility with innovative equipment, training facilities, and state-of-the-art operating rooms dedicated to research in 12 therapeutic areas. T3 Labs was founded in 1999 and is based in Atlanta, Georgia. |
Buy | - |
